Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for TMDX

Stock Name	TransMedics Group Inc
Ticker	TMDX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US89377M1099

Show aggregate TMDX holdings

News associated with TMDX

Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings Momentum: (RTTNews) - Several biotech and medical technology stocks posted notable gains in after-hours trading on Monday, with momentum driven by a mix of earnings optimism, clinical trial progress, and speculative positioning. While some names rallied on fresh developments, like TransMed - 2025-09-09 02:11:07
Needham & Company LLC Reiterates “Hold” Rating for TransMedics Group (NASDAQ:TMDX): Needham & Company LLC restated their hold rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research report report published on Monday morning,Benzinga reports. Several other equities research analysts have also recently weighed in on the company. Piper Sandler reiterated an “overweight” rating and set a $145.00 price target (up from $125.00) […] - 2025-08-26 03:04:48
Maryland State Retirement & Pension System Sells 1,544 Shares of TransMedics Group, Inc. (NASDAQ:TMDX): Maryland State Retirement & Pension System cut its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 13.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,758 shares of the company’s stock after selling 1,544 shares during the quarter. Maryland […] - 2025-08-14 05:17:08
Mutual of America Capital Management LLC Lowers Holdings in TransMedics Group, Inc. (NASDAQ:TMDX): Mutual of America Capital Management LLC lowered its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 3.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,888 shares of the company’s stock after selling 195 shares during the […] - 2025-08-13 05:46:47
Monday 8/11 Insider Buying Report: TMDX, PNFP: Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we - 2025-08-11 12:49:10
Wall Street Zen Upgrades TransMedics Group (NASDAQ:TMDX) to “Buy”: Wall Street Zen upgraded shares of TransMedics Group (NASDAQ:TMDX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning. A number of other equities research analysts also recently weighed in on TMDX. Canaccord Genuity Group lifted their target price on TransMedics Group from $129.00 […] - 2025-08-05 02:56:57
TransMedics Group (NASDAQ:TMDX) Trading 6.8% Higher After Analyst Upgrade: TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) rose 6.8% during mid-day trading on Monday after Wall Street Zen upgraded the stock from a hold rating to a buy rating. The company traded as high as $130.70 and last traded at $128.76. Approximately 501,417 shares were traded during mid-day trading, a decline of 63% from […] - 2025-08-05 02:20:49
Reviewing TransMedics Group (NASDAQ:TMDX) & Advanced Biomedical Technologies (OTCMKTS:ABMT): TransMedics Group (NASDAQ:TMDX – Get Free Report) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Volatility and Risk TransMedics Group has a […] - 2025-08-01 02:34:48
TransMedics (TMDX) Q2 Revenue Jumps 38%: Key PointsTransMedics Group (NASDAQ:TMDX) beat GAAP revenue and earnings estimates for the second quarter of 2025, with GAAP revenue up 38% year over year. - 2025-07-31 06:16:30
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $142.00: TransMedics Group (NASDAQ:TMDX – Free Report) had its target price lifted by Canaccord Genuity Group from $129.00 to $142.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other equities research analysts have also recently issued reports on TMDX. Needham & Company LLC […] - 2025-07-18 05:05:07
Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Price Target at $127.33: Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation […] - 2025-07-15 03:48:49
TransMedics Group, Inc. (NASDAQ:TMDX) Stake Boosted by OneDigital Investment Advisors LLC: OneDigital Investment Advisors LLC increased its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 52.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,989 shares of the company’s stock after buying an additional 2,065 shares during the quarter. OneDigital […] - 2025-07-11 05:09:03
Janney Montgomery Scott LLC Grows Position in TransMedics Group, Inc. (NASDAQ:TMDX): Janney Montgomery Scott LLC lifted its position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 129.9% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 8,799 shares of the company’s stock after purchasing an additional 4,972 shares during the period. Janney Montgomery Scott LLC’s holdings in TransMedics […] - 2025-07-03 04:42:50
Needham & Company LLC Reaffirms Hold Rating for TransMedics Group (NASDAQ:TMDX): TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “hold” rating reiterated by analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. A number of other research analysts also recently weighed in on the stock. Oppenheimer raised their price target on shares of TransMedics Group from $125.00 to $130.00 and […] - 2025-06-19 02:18:55
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages: Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating […] - 2025-06-17 02:32:45
GAMMA Investing LLC Boosts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX): GAMMA Investing LLC lifted its position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 43,744.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 105,226 shares of the company’s stock after purchasing an additional 104,986 shares during the quarter. GAMMA Investing LLC’s holdings […] - 2025-06-09 05:12:57
Needham & Company LLC Reiterates “Hold” Rating for TransMedics Group (NASDAQ:TMDX): TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “hold” rating restated by equities research analysts at Needham & Company LLC in a research note issued to investors on Tuesday,Benzinga reports. A number of other equities research analysts also recently weighed in on TMDX. Canaccord Genuity Group reaffirmed a “buy” rating and set a […] - 2025-06-05 02:19:08
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 6.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,657 shares of the company’s stock after acquiring an additional 1,096 shares during the […] - 2025-05-26 04:43:01
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?: Shares of TransMedics Group (NASDAQ: TMDX) recently bounded higher in response to a first-quarter earnings report that was a lot better than investors were expecting. Downward revenue guidance revisions and unwanted attention from short-sellers pushed the stock down late last yea - 2025-05-13 06:18:00
Northern Trust Corp Boosts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX): Northern Trust Corp lifted its position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 12.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 354,622 shares of the company’s stock after purchasing an additional 40,093 shares during the quarter. Northern Trust Corp […] - 2025-05-13 05:28:55
Stifel Financial Corp Acquires 1,544 Shares of TransMedics Group, Inc. (NASDAQ:TMDX): Stifel Financial Corp increased its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 20.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,968 shares of the company’s stock after acquiring an additional 1,544 shares during the period. Stifel […] - 2025-05-12 04:54:55
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by First Trust Advisors LP: First Trust Advisors LP trimmed its stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 29.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 42,106 shares of the company’s stock after selling 17,602 shares during the quarter. First Trust Advisors LP owned approximately […] - 2025-05-05 05:05:06
Mariner LLC Has $758,000 Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX): Mariner LLC lowered its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 4.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,156 shares of the company’s stock after selling 512 shares during the period. Mariner LLC’s holdings in TransMedics Group were […] - 2025-04-29 04:56:59
1 Beaten-Down Stock to Buy Right Now and Hold for a Decade: President Donald Trump's trade war is creating significant uncertainty. Equities plunged following his decision to impose tariffs on almost every country, then soared after he announced a 90-day pause on his expanded tariff plans. It's challenging to predict which way the market - 2025-04-24 08:45:00
Alliancebernstein L.P. Grows Position in TransMedics Group, Inc. (NASDAQ:TMDX): Alliancebernstein L.P. increased its position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 1.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 40,572 shares of the company’s stock after purchasing an additional 500 shares during the period. Alliancebernstein L.P.’s holdings in TransMedics Group were worth $2,530,000 at the end of the […] - 2025-04-17 05:08:49
Geode Capital Management LLC Acquires 8,954 Shares of TransMedics Group, Inc. (NASDAQ:TMDX): Geode Capital Management LLC lifted its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 772,744 shares of the company’s stock after purchasing an additional 8,954 shares during […] - 2025-04-15 05:00:54
Pictet Asset Management Holding SA Cuts Position in TransMedics Group, Inc. (NASDAQ:TMDX): Pictet Asset Management Holding SA lowered its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 5.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,434 shares of the company’s stock after selling 274 shares during the quarter. Pictet Asset Management Holding SA’s […] - 2025-04-11 05:56:54
Commonwealth Equity Services LLC Has $618,000 Holdings in TransMedics Group, Inc. (NASDAQ:TMDX): Commonwealth Equity Services LLC lifted its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 17.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,905 shares of the company’s stock after buying an additional 1,460 shares during the […] - 2025-04-04 04:26:50
Envestnet Portfolio Solutions Inc. Increases Position in TransMedics Group, Inc. (NASDAQ:TMDX): Envestnet Portfolio Solutions Inc. raised its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 7.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,721 shares of the company’s stock after purchasing an additional 317 shares during the period. Envestnet Portfolio […] - 2025-03-28 06:06:49
TransMedics Group (NASDAQ:TMDX) Receives Hold Rating from Needham & Company LLC: TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities researchers at Needham & Company LLC in a note issued to investors on Wednesday,Benzinga reports. Other analysts also recently issued reports about the company. Robert W. Baird decreased their price objective on TransMedics Group from $150.00 to $120.00 and set […] - 2025-03-28 04:02:49

iShares US Medical Devices UCITS ETF TMDX holdings

Date	Number of TMDX Shares Held	Base Market Value of TMDX Shares	Local Market Value of TMDX Shares	Change in TMDX Base Value	Current Price per TMDX Share Held	Previous Price per TMDX Share Held
2025-12-03 (Wednesday)	4,741	USD 664,214	USD 664,214	USD -7,918	USD 140.1	USD 141.77
2025-12-02 (Tuesday)	4,741	USD 672,132	USD 672,132	USD -41,009	USD 141.77	USD 150.42
2025-12-01 (Monday)	4,741	USD 713,141	USD 713,141	USD 19,485	USD 150.42	USD 146.31
2025-11-28 (Friday)	4,741	USD 693,656	USD 693,656	USD 2,655	USD 146.31	USD 145.75
2025-11-27 (Thursday)	4,741	USD 691,001	USD 691,001	USD 0	USD 145.75	USD 145.75
2025-11-26 (Wednesday)	4,741	USD 691,001	USD 691,001	USD -1,185	USD 145.75	USD 146
2025-11-25 (Tuesday)	4,741	USD 692,186	USD 692,186	USD 27,450	USD 146	USD 140.21
2025-11-24 (Monday)	4,741	USD 664,736	USD 664,736	USD 43,997	USD 140.21	USD 130.93
2025-11-21 (Friday)	4,741	USD 620,739	USD 620,739	USD 33,708	USD 130.93	USD 123.82
2025-11-20 (Thursday)	4,741	USD 587,031	USD 587,031	USD -45,750	USD 123.82	USD 133.47
2025-11-19 (Wednesday)	4,741	USD 632,781	USD 632,781	USD 77,752	USD 133.47	USD 117.07
2025-11-18 (Tuesday)	4,741	USD 555,029	USD 555,029	USD 17,400	USD 117.07	USD 113.4
2025-11-17 (Monday)	4,741	USD 537,629	USD 537,629	USD -7,633	USD 113.4	USD 115.01

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TMDX by Blackrock for IE00BMX0DF60

Show aggregate share trades of TMDX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -74 124.980* 98.89 Profit of 7,318 on sale
2025-11-04 BUY 37 122.210* 98.63
2025-10-30 SELL -111 139.450 120.800 122.665 USD -13,616 98.12 Loss of -2,724 on sale
2025-10-23 SELL -37 128.910 129.460 129.405 USD -4,788 97.22 Loss of -1,191 on sale
2025-10-22 BUY 74 119.540 124.870 124.337 USD 9,201 97.10
2025-10-20 BUY 37 119.900 121.320 121.178 USD 4,484 96.84
2025-10-16 BUY 37 115.680 118.510 118.227 USD 4,374 96.62
2025-09-25 BUY 296 113.900 114.950 114.845 USD 33,994 95.49
2025-06-27 SELL -74 131.450 133.020 132.863 USD -9,832 90.88 Loss of -3,106 on sale
2025-06-12 BUY 111 143.045 143.817 143.740 USD 15,955 87.96
2025-06-10 SELL -592 140.860 143.545 143.276 USD -84,820 87.14 Loss of -33,236 on sale
2025-06-09 SELL -703 139.400 140.680 140.552 USD -98,808 86.73 Loss of -37,837 on sale
2025-05-30 SELL -74 127.120 128.440 128.308 USD -9,495 84.58 Loss of -3,236 on sale
2025-05-19 BUY 37 122.100 122.410 122.379 USD 4,528 81.40
2025-05-09 SELL -185 111.500 120.930 119.987 USD -22,198 79.27 Loss of -7,533 on sale
2025-04-23 SELL -37 92.250 95.900 95.535 USD -3,535 77.62 Loss of -663 on sale
2025-04-17 SELL -37 88.240 88.390 88.375 USD -3,270 77.13 Loss of -416 on sale
2025-04-10 BUY 296 76.370 78.710 78.476 USD 23,229 76.78
2025-04-04 SELL -74 67.670 69.000 68.867 USD -5,096 77.10 Profit of 609 on sale
2025-04-02 SELL -74 73.110 73.590 73.542 USD -5,442 77.15 Profit of 267 on sale
2025-03-31 SELL -114 67.280 67.940 67.874 USD -7,738 77.39 Profit of 1,084 on sale
2025-03-19 SELL -37 70.330 72.302 72.105 USD -2,668 78.21 Profit of 226 on sale
2025-02-28 SELL -74 76.320 80.220 79.830 USD -5,907 80.18 Profit of 26 on sale
2025-02-21 BUY 256 71.950 76.783 76.300 USD 19,533 80.78
2025-02-05 BUY 108 74.570 75.230 75.164 USD 8,118 83.00
2025-02-04 BUY 144 72.140 73.800 73.634 USD 10,603 83.26
2025-01-29 SELL -36 65.530 67.080 66.925 USD -2,409 84.95 Profit of 649 on sale
2025-01-23 SELL -36 62.550 62.600 62.595 USD -2,253 87.55 Profit of 898 on sale
2025-01-02 SELL -70 66.500 68.910 68.669 USD -4,807 88.19 Profit of 1,366 on sale
2024-12-04 BUY 105 72.210 73.930 73.758 USD 7,745 91.59
2024-12-03 SELL -35 71.440 78.712 77.985 USD -2,729 92.34 Profit of 502 on sale
2024-12-02 SELL -420 85.140 87.020 86.832 USD -36,469 92.62 Profit of 2,430 on sale
2024-11-29 SELL -700 86.710 89.380 89.113 USD -62,379 92.85 Profit of 2,618 on sale
2024-11-27 SELL -105 87.110 87.570 87.524 USD -9,190 93.35 Profit of 612 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-74			124.980*		98.89 Profit of 7,318 on sale
2025-11-04	BUY	37			122.210*		98.63
2025-10-30	SELL	-111	139.450	120.800	122.665	USD -13,616	98.12 Loss of -2,724 on sale
2025-10-23	SELL	-37	128.910	129.460	129.405	USD -4,788	97.22 Loss of -1,191 on sale
2025-10-22	BUY	74	119.540	124.870	124.337	USD 9,201	97.10
2025-10-20	BUY	37	119.900	121.320	121.178	USD 4,484	96.84
2025-10-16	BUY	37	115.680	118.510	118.227	USD 4,374	96.62
2025-09-25	BUY	296	113.900	114.950	114.845	USD 33,994	95.49
2025-06-27	SELL	-74	131.450	133.020	132.863	USD -9,832	90.88 Loss of -3,106 on sale
2025-06-12	BUY	111	143.045	143.817	143.740	USD 15,955	87.96
2025-06-10	SELL	-592	140.860	143.545	143.276	USD -84,820	87.14 Loss of -33,236 on sale
2025-06-09	SELL	-703	139.400	140.680	140.552	USD -98,808	86.73 Loss of -37,837 on sale
2025-05-30	SELL	-74	127.120	128.440	128.308	USD -9,495	84.58 Loss of -3,236 on sale
2025-05-19	BUY	37	122.100	122.410	122.379	USD 4,528	81.40
2025-05-09	SELL	-185	111.500	120.930	119.987	USD -22,198	79.27 Loss of -7,533 on sale
2025-04-23	SELL	-37	92.250	95.900	95.535	USD -3,535	77.62 Loss of -663 on sale
2025-04-17	SELL	-37	88.240	88.390	88.375	USD -3,270	77.13 Loss of -416 on sale
2025-04-10	BUY	296	76.370	78.710	78.476	USD 23,229	76.78
2025-04-04	SELL	-74	67.670	69.000	68.867	USD -5,096	77.10 Profit of 609 on sale
2025-04-02	SELL	-74	73.110	73.590	73.542	USD -5,442	77.15 Profit of 267 on sale
2025-03-31	SELL	-114	67.280	67.940	67.874	USD -7,738	77.39 Profit of 1,084 on sale
2025-03-19	SELL	-37	70.330	72.302	72.105	USD -2,668	78.21 Profit of 226 on sale
2025-02-28	SELL	-74	76.320	80.220	79.830	USD -5,907	80.18 Profit of 26 on sale
2025-02-21	BUY	256	71.950	76.783	76.300	USD 19,533	80.78
2025-02-05	BUY	108	74.570	75.230	75.164	USD 8,118	83.00
2025-02-04	BUY	144	72.140	73.800	73.634	USD 10,603	83.26
2025-01-29	SELL	-36	65.530	67.080	66.925	USD -2,409	84.95 Profit of 649 on sale
2025-01-23	SELL	-36	62.550	62.600	62.595	USD -2,253	87.55 Profit of 898 on sale
2025-01-02	SELL	-70	66.500	68.910	68.669	USD -4,807	88.19 Profit of 1,366 on sale
2024-12-04	BUY	105	72.210	73.930	73.758	USD 7,745	91.59
2024-12-03	SELL	-35	71.440	78.712	77.985	USD -2,729	92.34 Profit of 502 on sale
2024-12-02	SELL	-420	85.140	87.020	86.832	USD -36,469	92.62 Profit of 2,430 on sale
2024-11-29	SELL	-700	86.710	89.380	89.113	USD -62,379	92.85 Profit of 2,618 on sale
2024-11-27	SELL	-105	87.110	87.570	87.524	USD -9,190	93.35 Profit of 612 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TMDX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	1,255,166	524	1,416,173	88.6%
2025-09-18	249,740	19,970	470,413	53.1%
2025-09-17	126,829	32	271,488	46.7%
2025-09-16	160,499	170	298,220	53.8%
2025-09-15	174,038	1,500	288,942	60.2%
2025-09-12	214,222	1,595	390,922	54.8%
2025-09-11	414,812	584	701,515	59.1%
2025-09-10	266,670	18	439,127	60.7%
2025-09-09	630,525	591	1,039,180	60.7%
2025-09-08	391,948	627	710,488	55.2%
2025-09-05	255,146	438	511,911	49.8%
2025-09-04	340,676	2,505	605,510	56.3%
2025-09-03	311,458	1,022	619,893	50.2%
2025-09-02	269,671	1,074	464,481	58.1%
2025-08-29	153,462	1,379	267,271	57.4%
2025-08-28	163,879	479	245,299	66.8%
2025-08-27	177,021	177	345,550	51.2%
2025-08-26	175,281	514	318,578	55.0%
2025-08-25	253,041	2,230	455,227	55.6%
2025-08-22	331,788	128,603	597,419	55.5%
2025-08-21	150,766	114	300,983	50.1%
2025-08-20	179,697	1,259	355,990	50.5%
2025-08-19	170,209	457	290,751	58.5%
2025-08-18	134,954	3,585	225,091	60.0%
2025-08-15	124,589	728	230,121	54.1%
2025-08-14	165,547	1,173	302,661	54.7%
2025-08-13	196,035	346	440,212	44.5%
2025-08-12	270,653	4,989	505,720	53.5%
2025-08-11	485,447	42,720	787,024	61.7%
2025-08-08	168,139	564	300,904	55.9%
2025-08-07	226,189	468	425,322	53.2%
2025-08-06	314,522	5,091	585,908	53.7%
2025-08-05	312,763	52	550,380	56.8%
2025-08-04	468,176	7,693	789,026	59.3%
2025-08-01	479,329	3,613	807,413	59.4%
2025-07-31	1,057,698	3,606	1,734,306	61.0%
2025-07-30	544,429	0	792,067	68.7%
2025-07-29	288,214	0	524,330	55.0%
2025-07-28	173,083	0	378,242	45.8%
2025-07-25	138,616	184	284,429	48.7%
2025-07-24	242,556	151	404,987	59.9%
2025-07-23	236,421	0	510,823	46.3%
2025-07-22	313,396	560	798,658	39.2%
2025-07-21	366,139	1,221	908,813	40.3%
2025-07-18	157,155	242	358,045	43.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam